Keyphrases
Myocardial Infarction
100%
Bone Marrow Cells
83%
Infarcted Heart
58%
Cardiac Function
55%
Bone Marrow
49%
Angiogenesis
48%
Human Mesenchymal Stem Cells (hMSCs)
44%
Noncardiac Surgery
41%
Postoperative Outcomes
37%
Hypoxemia
37%
Pain Management
37%
Cardiovascular Complications
34%
Uterine Cells
34%
Stem Cell Factor
34%
Aged Mice
32%
Length of Hospital Stay
30%
Reconstitution
27%
Infarcted
26%
Stem Cells
24%
Mode of Delivery
24%
Cell Delivery
24%
Female Rats
24%
Postoperative Hypoxemia
24%
Heart Failure
22%
Allogeneic
22%
Myocardium
21%
Gene Therapy
21%
Engraftment
21%
Immunogenicity
21%
Prospective Cohort Study
21%
C-kit
21%
Minimally Invasive
20%
Cardiac Dysfunction
20%
Overexpression
20%
Proangiogenic Cells
20%
Myocardial Ischemia
20%
Atrial Arrhythmia
18%
Thoracic Epidural Analgesia
18%
Anesthetic Management
18%
Transjugular Intrahepatic Portosystemic Shunt
18%
Membrane Binding
18%
Targeted Gene Delivery
18%
Cardiac Dilation
18%
Cohort Analysis
18%
Uterine Tissue
18%
Neural Function
18%
Bone Marrow Progenitor Cells
18%
Extrusion
18%
Allogeneic Mesenchymal Stem Cells
18%
Cell-based
18%
Medicine and Dentistry
Myocardial Infarction
63%
Angiogenesis
55%
Noncardiac Surgery
51%
Bone Marrow Cell
45%
Heart Function
43%
Hypoxemia
40%
Bone Marrow Stromal Cell
38%
Myocardium
38%
Systematic Review
37%
Stem Cell
37%
Cohort Analysis
37%
Hematopoietic Stem Cell
32%
Infarction
31%
Major Histocompatibility Complex
26%
Analgesia
26%
Observational Study
25%
Engraftment
23%
Surgery
23%
Cardiovascular Disease
23%
Immunogenicity
21%
In Vitro
21%
Mesenchymal Stem Cell
21%
Diagnosis
21%
Symptom
21%
Prospective Cohort Study
21%
Coronary Artery Ligation
19%
Precursor
18%
Heart Atrium Arrhythmia
18%
Transjugular Intrahepatic Portosystemic Shunt
18%
Cell Proliferation
18%
Brain Tissue
18%
Elastin
18%
Diabetic Neuropathy
18%
Heart Muscle Injury
18%
Paracentesis
18%
Epidural Analgesia
18%
Retrospective Cohort Study
18%
Spinal Cord Stimulator
18%
Electrostimulation
18%
Pneumonectomy
18%
Neurostimulation
18%
Hemangioblast
18%
Superior Mesenteric Artery Syndrome
18%
Gene Targeting
18%
Smooth Muscle Cell
18%
Cell Migration
18%
Stomach Paresis
18%
Interventional Therapy
18%
Rib Fracture
18%
Cell Based Gene Therapy
18%